Immunology Seminar Series

The TRI Thursday Immunology Seminar series will feature exciting research updates from ongoing early-to-mid career Immunology researchers, covering basic to translational research topics in immunology and immunotherapy.

For general enquires regarding the TRI Thursday Immunology Seminar Series, please contact:

Tommy Liu and/or Janin Chandra


Date Speaker Title Speaker bio
Thursday 30 June 2022
Seminar Room 2003 &
A/Prof Kirsty Short
'A history of high-fat diet induced obesity increases influenza severity in a canonical NLRP3-dependent manner '
A/Prof Kirsty Short is head of the Respiratory Virus Pathogenesis Laboratory at the University of Queensland. She investigates the pathogenesis of human influenza virus, avian influenza virus and SARS-CoV-2. Her work covers a broad range of topics including viral evolution, the role of host comorbidities in viral disease and the effect of age on the innate immune response.
Thursday 16 June 2022
Seminar Room 2004 &
Dr Peter Woolf

Dr Kira Sun

'Scalable and Highly Sensitive Single Cell RNA-seq through Combinatorial Barcoding'
'Large field-of-view, high-resolution spatially resolved transcriptomics using DNA nanoball patterned array'
Peter completed his PhD in the calcium handling in cardiomyocytes in the mouse model of Duchenne muscular dystrophy in 2003. Since then Peter has worked in industry in various roles such as supporting the market launch of Seahorse bioscience for mitochondrial respiration, the first installation of a single use bioreactor at CSL, and improving automation and record keeping in pharmaceutical manufacturing facilities. At Decode Peter has assisted QLD’s COVID response by assisting Pathology QLD and QML to greatly increase their throughput. He is now focussing on improving and reducing the cost of single cell and spatial technologies.
Dr Kira Xiaohuan Sun joined BGI Research, a not-for-profit scientific research institute under the BGI Group, as a senior researcher in 2017 after obtaining her Ph.D. of Biotechnology in Ghent University, Belgium. She has engaged in the development of novel high-throughput metagenome sequencing technologies and research in environmental microbiome genome study, plant molecular biology. Kira has several first-author publications in leading scientific journals such as Nature Communications, Plant Biotechnology Journal, and Journal of Fungi through international collaborations. She currently acts as the Field Application Scientist supporting the applications of BGI spatial omics innovation STOmics® in Australia and New Zealand.
Thursday 2 June 2022
Seminar Room 2003 &
Dr. Susan Millard 'Fragmentation of tissue-resident macrophages during isolation confounds analysis of single cell preparations from mouse hematopoietic tissue'
Dr Millard has a background in bone research, first indulged during a post-doctoral position at the University of California – San Francisco. On returning to Australia, she investigated stem cell therapies for genetic bone disorders before joining the Bones and Immunology team at Mater Research. Her interests revolve around understanding the role of tissue-resident macrophages in supporting functions as diverse as fracture healing and haematopoiesis.
Thursday 19 May 2022
Dr Nicole Campbell 'Deciphering the direct and indirect effects of interferon epsilon in ovarian cancer'
Following completion of her PhD in Immunology at Trinity College Dublin in Ireland in 2018, Dr Campbell commenced a postdoctoral research position with Prof Paul Hertzog at the Hudson Institute in January 2019. Her current research is centered on type I interferons, a family of pleiotropic cytokines with well-characterised functions in anti-viral and anti-cancer immunity. Her primary research focus is investigating the potential of interferon epsilon, a unique type I interferon discovered by Prof Hertzog’s lab, as a treatment for ovarian cancer. Furthermore, Dr Campbell currently leads other ongoing research projects within Prof Hertzog’s lab including studies on the innate immune response to COVID-19, characterisation of immunoregulation by interferons in the peritoneal cavity, and identification of novel protein interactions during interferon signalling.

Thursday 5 May 2022


Selwin Samuel 'Pathogen associated molecular patterns exacerbate Neurogenic Heterotopic Ossification after spinal-cord injury'
Selwin works in the Stem Cell Biology laboratory under the supervision of Prof Jean-Pierre Levesque and Dr Kylie Alexander at Translational Research Institute in Woolloongabba, Brisbane. Selwin is a dentist from India and also has expertise in the field of forensics. After working as a forensic odontologist in India for a few months, Selwin moved to Brisbane to do a PhD. In his PhD, he is aiming to discover how infections and gut microbiome influence the development of Neurogenic Heterotopic Ossification (NHO) after spinal-cord Injury, in experimental pre-clinical models. 

Thursday 21 April 2022


Dr Camille Guillerey 'Utilising NK cells against Blood Cancers'
Dr Camille Guillerey is a Senior Research Officer and Career Track Fellow in the Cancer Immunotherapies (Radford) Group at Mater Research. She leads a small team of young scientists and students performing research on blood cancers. 
Camille’s research is currently focused on Natural Killer cells, a population of immune cells that recognise and kill cancer cells. She is interested in understanding how Natural Killer cells interact with other immune cells to develop protective immune responses since improved basic knowledge of immunological processes will help design new therapies for various human pathologies such as cancer, infectious disease or autoimmune disorders. In addition, Camille aims to identify mechanisms that may prevent Natural Killer cells from eliminating cancer cells and apply these findings to develop new treatments for childhood leukemia.

Thursday 7 April 2022


A/Prof Severine Navarro 'Environmental factors that influence early life immune development'
A/Prof Severine Navarro leads the Mucosal Immunology Group at QIMR Berghofer and is the Director of Discovery Science at the Centre for Children Nutrition Research (QUT). She is a Lead Investigator in clinical studies at the Royal Brisbane Women’s Hospital, Wesley and Mackay hospitals as well as ICON Cancer Centre to define microbiome/metabolome-immune interactions in celiac disease and cancer. She is an Academic Lead Investigator in a placebo-controlled clinical trial aiming at defining the rate of allergy onset following prophylactic antibiotics exposure administered during elective caesarean section and the impact on breastmilk and infant gut microbiome.
A/Prof Navarro also leads a longitudinal cohort study in Papua New Guinea (The Infant Gut Health Study) that looks at the impact of helminths infection on the infant microbiome and disease susceptibility. She has also acquired expertise in drug development and has worked in partnership with Vifor Pharma, Boehringer Ingelheim, Merial, Takeda and Janssen Pharmaceutical.

Thursday 24 March 2022


Dr Janin Chandra, UQDI 'The Mononuclear Phagocyte System: Synthesizer of Immunity and Resistance'
Dr. Janin Chandra leads a research program elucidating mechanisms of malfunctioning mononuclear phagocytes, with a focus on their roles in cancer progression. Her vision is to restore the functionality of these cells to increase tumour inflammation and responsiveness to T cell targeted immunotherapies.

Thursday 10 March 2022


Dr Thomas Ashhurst 'Comprehensive single-cell and spatial mapping of immunity in health and disease: viral encephalitis and COVID-19'
Dr. Thomas Ashhurst is a high-dimensional cytometry and single-cell specialist with the Sydney Cytometry Core Research Facility, and an Honorary Research Fellow with the Infection, Immunity, and Inflammation Theme, School of Medical Sciences, at The University of Sydney.  
He also leads a multi-disciplinary ‘systems immunology’ initiative, seeking to comprehensively map the immune response to inflammation and emerging infectious diseases, including viral encephalitis and COVID-19, using high-dimensional single-cell and imaging methods in addition to advanced computational analysis approaches.

Thursday 24 February 2022


Dr Larisa Labzin 'Inflammation in acute respiratory viral infection: how does our innate immune system sense and respond to viruses?' Dr Larisa Labzin is a UQ Amplify Fellow at the Institute for Molecular Bioscience (IMB), leading a research team focused on deciphering how inflammation is triggered during acute viral infection. Her research aims to identify novel targets to treat pathological inflammation without compromising host defence. 

Thursday 10 February 2022


Dr Jazmina Gonzalez Cruz 'Adding a new sting to our bow: spatial profiling of Oropharyngeal Head and Neck cancers' 'Dr. Gonzalez Cruz leads a collaboration project with the Technological University of Denmark and Princess Alexandra Hospital to develop a pipeline to de-risk the design and manufacture of personalized cancer immunotherapies.'

2020 Thursday Immunology Seminar

Date Speaker Title
17 December Professor Burkhard Becher T cell/myeloid communication in inflammation.
5 November

Dr I-Mei Siu

Dr Tanya Bondar

Dr Karen Honey

Meet the Editors of the American Association of Cancer Research (AACR)

22 October  Ahmed Mehdi

"GLACIER: A web interface for visualizing single-cell gene set annotation enrichment"

24 September Meg Donovan and Thomas Schultz

"In vivo correlates of Rp105-dependent host control of Mycobacterium tuberculosis infection"

10 September Dr Bree Tillett

'Specialised dietary intervention in human type 1 diabetes'

27 August  Dr Sandra Depelsenaire

'Microarray patch delivery of un-adjuvanted influenza vaccine induces potent and broad-spectrum immune responses in a phase I clinical trial'

13 August  Dr Meihua Yu and Dr Janin Chandra 

'Development of cancer immunotherapy: nanovaccines and small-molecule targets' presented by Dr Meihua Yu 

30 July Joshua Monteith and Amy Pham 

'Targeting Cloaking Antibody: Improving plasmapheresis and seizing the means of production' presented by Joshua Monteith

'Prevalence, Mechanisms and Treatment of Cloaking Antibodies in P.Aeruginosa Lung Infections' presented by Amy Pham 

12 March Dr Kelly-Anne Masterman  Hear from Dr Kelly-Anne Masterman from one of TRI's commercial incubators, Microba as she discusses Drugs from Bugs.  

2019 Thursday Immunology Seminar

Date Speaker Theme
20 June Sheena Daignault (Haass Group) Inflammatory Diseases
4 July Anne-Sophie Bergot (Thomas Group) Innate Immunity & Infectious Diseases
18 July Tommy Liu (Thomas Group) Immunotherapy for Cancer and Autoimmune Diseases
1 August Jessica Whyte (Brown Group) Inflammatory Diseases
1 August Md Moniruzzaman (Hasnain Group) Inflammatory Diseases
15 August Dr Carmen Mathmann (Blumenthal Group) Innate Immunity & Infectious Diseases
15 August Dr Janin Chandra (Frazer Group) Innate Immunity & Infectious Diseases
29 August Jeniffer Loaiza (Hamilton-Williams Group) Immunotherapy for Cancer and Autoimmune Diseases
12 September Katharina Ronacher (Ronacher Group) Inflammatory Diseases
12 September Adrian Gemiarto (Ronacher Group) Inflammatory Diseases
26 September Tom Schultz (Blumenthal Group) Innate Immunity & Infectious Diseases
26 September Chenhao Zhou (Frazer Group) Innate Immunity & Infectious Diseases
10 October Zhen Zeng (Wells group) Immunotherapy for Cancer and Autoimmune Diseases
24 October Ismail Sebina (Phipps group QIMR) Inflammatory Diseases
7 November Meg Donovan (Blumenthal Group) Innate Immunity & Infectious Diseases
7 November Dr Eduardo Albornoz (Woodruff Group)  Innate Immunity & Infectious Diseases
21 November Meihua Yu (Frazer Group) Immunotherapy for Cancer and Autoimmune Diseases
5 December Quan Nguyen (Frazer Group) Immunotherapy for Cancer and Autoimmune Diseases

2018 Archive

Date Speaker(s) Title(s)
29/03/2018 Zhen Zeng (Wells Lab, UQDI)

Influence of IFNg and CXCR3 on anti-tumour CD8+ T-cells in the regression of SCC.


Rebecca Coll (Schroder Lab, IMB)

Dave Boucher (Schroder Lab, IMB)

Inflammasomes - Key molecules in inflammation and novel targets for the treatment of inflammatory diseases

Caspase-1 self-processing is an intrinsic mechanism regulating inflammasome signaling


Ran Wang (Hasnain Lab, Mater-UQ)

Sahar Keshvari (Hasnain Lab, Mater-UQ)

Targeting Nuclear Receptor ROR alpha in Treating Intestinal Inflammation

Development of IL-22 - Based therapy for Type 2 Diabetes


Anne-Sophie Bergot (Hamilton-Thomas Lab, UQDI)

Jeremy Brooks (Steptoe Lab, UQDI)

Islet-specific liposomes induced diabetes protection is dependent on islet-specific regulatory T cells reprogramming.

How to 'B' self-tolerant


Nazhifah Salim (Leggatt Lab, UQDI)

Allie Lam (Mattarollo Lab, UQDI)

Characterization of 4-1BB Immunomodulatory Molecule on Skin T cells in Non-melanoma Skin Cancer.

Driving tumour-specific responses using nanoemulsions delivering glycolipid and cognate antigen to Clec9A+CD8a+ DCs in mice


Eduardo Albornoz (Woodruff Lab, SBMS)

Paula Kuo (Frazer Lab, UQDI)

The inflammasome component ASC plays a pathological role in Parkinson Disease.

Effective migration of HPV16E7-expressing skin dendritic cells to the draining lymph node is dependent on HPV16E7-Rb interaction.


Kelly-Anne Masterman (Radford Lab, Mater-UQ)

Samuel Lukowski (Frazer/Coin Lab, IMB)

Harnessing CD141+ Dendritic Cells (DC) for immunotherapy

Identifying cell subpopulations and rare viral transcripts with single cell RNA-seq


Claudia Stocks (Sweet Lab, IMB)

Kaustav Das Gupta (Sweet Lab, IMB)

Zinc as a novel antimicrobial weapon of macrophages

HDAC7: one of the missing links in macrophage metabolism


Takumi Kobayashi (Mattarollo Lab, UQDI)

Metabolic regulation of NK cells in B cell lymphoma


Kelvin Tuong (Frazer Lab, UQDI)

Megan Soon (Haque Lab, QIMR-B)

Single-cell RNA-seq of antigen-presenting cells in HPV16 E7 oncoprotein expressing skin.

Lineage tracing of effector to memory transitions in CD4+ T cells using single-cell genomics


Aimee Hanson (Brown Lab, QUT)

An Immunosequencing approach to interrogating the T-cell Repertoire in Ankylosing Spondylitis Patients.


Ambika Murthy (Sweet Lab, IMB)

Meriem B Tan (Brown Lab, QUT)

Complexity of interactions between uro-pathogenic E.coli and the innate immune system



Yoke Lee (Radford Lab, Matter-UQ)

Tommy Liu (Thomas Lab, UQDI)

Whole blood human dendritic cell immunoprofiling in melanoma patients

Phenotyping dendritic cells in liposome based immunotherapy


Tom Schultz (Blumenthal Lab, UQDI)

Dan Kerage (Mattarollo, UQDI)

Molecular mechanisms of RP105-dependent macrophage activation

Pressing the accelerator: NKT-targeting vaccine and anti-4-1BB combination therapy  eradicates acute myeloid leukemia


Special Seminar: ASI Visiting Speaker

Professor Joel Ernst (UCSF)

The Immunological Challenges and Opportunities of Tuberculosis

Find out more >


Irina Buckle (Hamilton-Williams Lab, UQDI)



Md Moniruzzaman (Hasnain Lab, Mater-UQ)

Meg Donovan (Blumenthal Lab, UQDI)

Interleukin-22: a potential therapy to control intestinal inflammation

Molecular drivers of mycobacteria-induced type 1 interferon responses


Ahmed Mehdi (Thomas Lab, UQDI)

Jessica He (Wells Lab, UQDI)

Improved prediction models of type-1 diabetes progression

Understanding the contribution of Tregs to squamous cell carcinoma establishment in UV-immunosuppressed hosts


Meihua Yu (Frazer lab, UQDI)

Jazmina L Gonzalez Cruz (Wells Lab, UQDI)

Development of Highly Immunogenic Minimalist Nanovaccines Against HPV-associated Cancers